patients

4:13PM
Printer-friendly version

The original OHIP+ provided limited coverage to a population that largely didn’t need assistance.


1:18PM
Printer-friendly version

U.S. pharmaceutical innovation has been disproportionately funded by U.S. consumers of patented drugs.


12:33PM
Printer-friendly version

Insurance companies are the principal beneficiaries of Ontario’s new publicly-funded pharmacare program.